Sulzer (SUN) Q3 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 TU earnings summary
13 Oct, 2026Executive summary
Jan–Sep order intake reached CHF 2,749.3m, up 1.8% YoY organically; growth entered the full-year outlook range and guidance was confirmed.
Q3 development reflected the anticipated back-end-loaded year, with order intake progressing through the year.
Financial highlights
Jan–Sep order intake was CHF 2,749.3m versus CHF 2,776.9m in Jan–Sep 2025, a 1.8% organic increase.
Outlook and guidance
Full-year guidance was confirmed, based on a solid order pipeline and barring unforeseen events.
Q3 order intake development was in line with the projected increase and expected back-end-loaded year.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Sulzer
- Record profitability and cash flow in 2023 underpin 2024 growth guidance.SUN
H2 2023 - EBITDA margin rose to 15.5% as Flow and Services grew; 2026 guidance reaffirmed.SUN
H1 2026 - Q1 2026 order intake fell 8.6% year-over-year, but guidance and outlook for 2026 remain positive.SUN
Q1 2026 TU - Record sales, profit, and margins support a higher dividend and positive 2026 outlook.SUN
H2 2025 - Order intake recovers, Services grow double digits, Chemtech hit by delays; guidance reaffirmed.SUN
Q3 2025 TU - Sales, EBITDA, and net income up; Chemtech lagged, outlook and dividend increased.SUN
H1 2025 - Order and sales growth drove higher profitability and upgraded 2024 guidance.SUN
H1 2024 - Targets above-market growth, >17% EBITDA margin, >22% ROCE, driven by innovation and efficiency.SUN
CMD 2024 - Double-digit sales and order growth, higher margins, and strong 2025 outlook driven by backlog.SUN
H2 2024